share_log

中國中藥:截至二零二四年二月二十九日止月份之股份發行人的證券變動月報表

TRAD CHI MED: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 29 FEBRUARY 2024

香港交易所 ·  Mar 1 03:40
Summary by Moomoo AI
中國中藥控股有限公司(股份代號:00570)已於2024年3月1日向香港交易及結算所有限公司提交了截至2024年2月29日的證券變動月報表。報表顯示,該月份內公司的已發行股份沒有變動,並且所有股份類別均不適用於香港聯交所上市。公司確認,根據《上市規則》第十九B章的要求,所有發行的證券均已獲得董事會的正式授權和批准,並且已履行所有上市的先決條件。此外,所有相關的法律文件均已正式存檔,並且所有交易均已完成且款項已繳付。報表由聯席公司秘書趙東吉呈交。
中國中藥控股有限公司(股份代號:00570)已於2024年3月1日向香港交易及結算所有限公司提交了截至2024年2月29日的證券變動月報表。報表顯示,該月份內公司的已發行股份沒有變動,並且所有股份類別均不適用於香港聯交所上市。公司確認,根據《上市規則》第十九B章的要求,所有發行的證券均已獲得董事會的正式授權和批准,並且已履行所有上市的先決條件。此外,所有相關的法律文件均已正式存檔,並且所有交易均已完成且款項已繳付。報表由聯席公司秘書趙東吉呈交。
China Pharmaceutical Holdings Limited (Stock Code: 00570) has filed with Hong Kong Trading and Settlement Limited on 1 March 2024 the Monthly Securities Change Report for the year ended 29 February 2024. The report shows that the company's issued shares during the month were unchanged and not all share classes are eligible for listing on the Hong Kong Stock Exchange. The Company confirms that all securities issued have been formally authorized and approved by the Board of Directors in accordance with the requirements of Chapter 19B of the Listing Rules and that all the listed prerequisites have been met. In addition, all relevant legal documents have been formally archived and all transactions have been completed and payments have been paid. The report was presented by the Joint Company Secretary Zhao Dongji.
China Pharmaceutical Holdings Limited (Stock Code: 00570) has filed with Hong Kong Trading and Settlement Limited on 1 March 2024 the Monthly Securities Change Report for the year ended 29 February 2024. The report shows that the company's issued shares during the month were unchanged and not all share classes are eligible for listing on the Hong Kong Stock Exchange. The Company confirms that all securities issued have been formally authorized and approved by the Board of Directors in accordance with the requirements of Chapter 19B of the Listing Rules and that all the listed prerequisites have been met. In addition, all relevant legal documents have been formally archived and all transactions have been completed and payments have been paid. The report was presented by the Joint Company Secretary Zhao Dongji.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more